Skip to Content

Enwei Pharmaceutical Co Ltd Class A 301331

Morningstar Rating
CNY 38.03 +0.32 (0.85%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

301331 is trading at a 27% discount.
Price
CNY 37.82
Fair Value
CNY 82.59
Uncertainty
High
1-Star Price
CNY 59.15
5-Star Price
CNY 67.23
Economic Moat
Nsbt
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 301331 is a good fit for your portfolio.

Trading Information

Previous Close Price
CNY 37.71
Day Range
CNY 37.2238.25
52-Week Range
CNY 27.9551.79
Bid/Ask
CNY 38.03 / CNY 38.05
Market Cap
CNY 2.67 Bil
Volume/Avg
523,147 / 887,575

Key Statistics

Price/Earnings (Normalized)
Price/Sales
3.43
Dividend Yield (Trailing)
4.21%
Dividend Yield (Forward)
4.21%
Total Yield
4.24%

Company Profile

Enwei Pharmaceutical Co Ltd is engaged in the research and development, production and sales of proprietary Chinese medicines and chemical medicines.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees
1,610

Comparables

Valuation

Metric
301331
002773
600211
Price/Earnings (Normalized)
19.7312.02
Price/Book Value
2.402.443.51
Price/Sales
3.434.893.75
Price/Cash Flow
38.1516.459.57
Price/Earnings
301331
002773
600211

Financial Strength

Metric
301331
002773
600211
Quick Ratio
6.552.74
Current Ratio
7.142.87
Interest Coverage
74.52
Quick Ratio
301331
002773
600211

Profitability

Metric
301331
002773
600211
Return on Assets (Normalized)
5.69%13.33%17.12%
Return on Equity (Normalized)
6.84%14.60%23.66%
Return on Invested Capital (Normalized)
7.12%14.05%19.20%
Return on Assets
301331
002773
600211
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class ACffsfmnqmGbm$72.4 Bil
MKKGY
Merck KGaA ADRXnblwzsclPhswm$70.8 Bil
HLN
Haleon PLC ADRHskvywySxv$38.2 Bil
VTRS
Viatris IncCmkywtgscHks$13.6 Bil
RDY
Dr Reddy's Laboratories Ltd ADRNphtjmkpzGynx$12.5 Bil
CTLT
Catalent IncGrpglxdpYcncjk$10.1 Bil
PRGO
Perrigo Co PLCSwwrrmrTrmm$4.3 Bil
CURLF
Curaleaf Holdings IncSxvtzkvtJsbm$3.7 Bil
PBH
Prestige Consumer Healthcare IncQfcsygfqLvqsg$3.5 Bil
GTBIF
Green Thumb Industries IncZqfffggydCstb$2.9 Bil

Sponsor Center